According to Lipocine's latest financial reports the company's current EPS (TTM) is -$2.88. In 2022 the company made an earnings per share (EPS) of -$2.65 a decrease over its 2021 EPS that were of -$0.22.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$3.01 | 13.72% |
2022 | -$2.65 | 1094.12% |
2021 | -$0.22 | -97.5% |
2020 | -$8.87 | -20% |
2019 | -$11.09 | -9.09% |
2018 | -$12.20 | -47.12% |
2017 | -$23.06 | -0% |
2016 | -$23.06 | -4.93% |
2015 | -$24.26 | -31.63% |
2014 | -$35.48 | 74.47% |
2013 | -$20.33 | -99.35% |
2012 | -$3,120 |